Composition and dynamics of the respiratory tract microbiome in intubated patients

Microbiome

Volumn 4, Issue , 2016, Pages

  Kelly, Brendan J ^a   Imai, Ize ^a   Bittinger, Kyle ^b   Laughlin, Alice ^b   Fuchs, Barry D ^a   Bushman, Frederic D ^b   Collman, Ronald G ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Antibiotics; Human microbiome; Mechanical ventilation; Pneumonia; Respiratory failure; Ventilator associated pneumonia

Indexed keywords

AZITHROMYCIN; AZTREONAM; CEFEPIME; CEFTRIAXONE; CLINDAMYCIN; COTRIMOXAZOLE; DAPTOMYCIN; LEVOFLOXACIN; MEROPENEM; METRONIDAZOLE; PIPERACILLIN PLUS TAZOBACTAM; RIFAXIMIN; RNA 16S; SULTAMICILLIN; VANCOMYCIN; BACTERIAL DNA;

ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; BIOINFORMATICS; BRONCHOSCOPY; CLINICAL ARTICLE; DNA PURIFICATION; FEMALE; GENE SEQUENCE; HUMAN; LOWER RESPIRATORY TRACT INFECTION; MALE; MICROBIAL COMMUNITY; MIDDLE AGED; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESPIRATORY FAILURE; RESPIRATORY TRACT INTUBATION; TRACHEAL ASPIRATION PROCEDURE; CASE CONTROL STUDY; CRITICAL ILLNESS; ENDOTRACHEAL INTUBATION; GENETIC VARIATION; GENETICS; INTENSIVE CARE UNIT; LONGITUDINAL STUDY; MICROBIOLOGY; MICROFLORA; OROPHARYNX; PATHOLOGY; PNEUMONIA, VENTILATOR-ASSOCIATED; RESPIRATORY TRACT INFECTIONS; SEQUENCE ANALYSIS; TRACHEA; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BRONCHOSCOPY; CASE-CONTROL STUDIES; CRITICAL ILLNESS; DNA, BACTERIAL; FEMALE; GENETIC VARIATION; HUMANS; INTENSIVE CARE UNITS; INTUBATION, INTRATRACHEAL; LONGITUDINAL STUDIES; MALE; MICROBIOTA; MIDDLE AGED; OROPHARYNX; PNEUMONIA, VENTILATOR-ASSOCIATED; RESPIRATION, ARTIFICIAL; RESPIRATORY TRACT INFECTIONS; RNA, RIBOSOMAL, 16S; SEQUENCE ANALYSIS, RNA; TRACHEA;

EID: 84996559039     PISSN: None     EISSN: 20492618     Source Type: Journal    
DOI: 10.1186/s40168-016-0151-8     Document Type: Article

References (64)

1. Niederman MS, Mandell LA, Anzueto A, Bass JB, Broughton WA, Campbell GD, et al. Guidelines for the management of adults with communityacquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med. 2001;163:1730-54
2. Fine MJ, Smith MA, Carson CA, Mutha SS, Sankey SS, Weissfeld LA, et al. Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis. JAMA. 1996;275:134-41
3. Sopena N, Heras E, Casas I, Bechini J, Guasch I, Pedro-Botet ML, et al. Risk factors for hospital-acquired pneumonia outside the intensive care unit: a case-control study. Am J Infect Control. 2014;42:38-42
4. Ross JS, Normand S-LT, Wang Y, Ko DT, Chen J, Drye EE, et al. Hospital volume and 30-day mortality for three common medical conditions. N Engl J Med. 2010;362:1110-8
5. Krumholz HM, Lin Z, Keenan PS, Chen J, Ross JS, Drye EE, et al. Relationship between hospital readmission and mortality rates for patients hospitalized with acute myocardial infarction, heart failure, or pneumonia. JAMA. 2 013;309:587-93
6. Esperatti M, Ferrer M, Giunta V, Ranzani OT, Saucedo LM, Bassi G, et al. Validation of predictors of adverse outcomes in hospital-acquired pneumonia in the ICU*. Crit Care Med. 2013;41:2151-61
7. Klompas M. Complications of mechanical ventilation-the CDC's new surveillance paradigm. N Engl J Med. 2013;368:1472-5
8. Rello J, Quintana E, Ausina V, Castella J, Luquin M, Net A, et al. Incidence, etiology, and outcome of nosocomial pneumonia in mechanically ventilated patients. Chest. 1991;100:439-44
9. Heyland DK, Cook DJ, Griffith L, Keenan SP, Brun-Buisson C. The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient. Am J Respir Crit Care Med. 1999;159:1249-56
10. Bercault N, Boulain T. Mortality rate attributable to ventilator-associated nosocomial pneumonia in an adult intensive care unit: a prospective case-control study. Crit Care Med. 2001;29:2303-9
11. Rello J, Ollendorf DA, Oster G, Vera-Llonch M, Bellm L, Redman R, et al. EPidemiology and outcomes of ventilator-associated pneumonia in a large us database. Chest J. 2002;122:2115-21
12. Nguile-Makao M, Zahar J-R, Français A, Tabah A, Garrouste-Orgeas M, Allaouchiche B, et al. Attributable mortality of ventilator-associated pneumonia: respective impact of main characteristics at ICU admission and VAP onset using conditional logistic regression and multi-state models. Intensive Care Med. 2010;36:781-9
13. Bekaert M, Timsit J-F, Vansteelandt S, Depuydt P, Vésin A, Garrouste-Orgeas M, et al. Attributable mortality of ventilator-associated pneumonia: a reappraisal using causal analysis. Am J Respir Crit Care Med. 2011;184:1133-9
14. Melsen WG, Rovers MM, Groenwold RHH, Bergmans DCJJ, Camus C, Bauer TT, et al. Attributable mortality of ventilator-associated pneumonia: a meta-analysis of individual patient data from randomised prevention studies. Lancet Infect Dis. 2013;13:665-71
15. Ewig S, Torres A, El-Ebiary M, Fábregas N, Hernández C, González J, et al. Bacterial colonization patterns in mechanically ventilated patients with traumatic and medical head injury. Incidence, risk factors, and association with ventilator-associated pneumonia. Am J Respir Crit Care Med. 1999;159:188-98
16. Sirvent JM, Torres A, Vidaur L, Armengol J, de Batlle J, Bonet A. Tracheal colonisation within 24 h of intubation in patients with head trauma: risk factor for developing early-onset ventilator-associated pneumonia. Intensive Care Med. 2000;26:1369-72
17. Hayon J, Figliolini C, Combes A, Trouillet J-L, Kassis N, Dombret MC, et al. Role of serial routine microbiologic culture results in the initial management of ventilator-associated pneumonia. Am J Respir Crit Care Med. 2002;165:41-6
18. Michel F, Franceschini B, Berger P, Arnal J-M, Gainnier M, Sainty J-M, et al. Early antibiotic treatment for BAL-confirmed ventilator-associated pneumonia: a role for routine endotracheal aspirate cultures. Chest. 2005;127:589-97
19. Boots RJ, Phillips GE, George N, Faoagali JL. Surveillance culture utility and safety using low-volume blind bronchoalveolar lavage in the diagnosis of ventilator-associated pneumonia. Respirology. 2008;13:87-96
20. Brusselaers N, Labeau S, Vogelaers D, Blot S. Value of lower respiratory tract surveillance cultures to predict bacterial pathogens in ventilator-associated pneumonia: systematic review and diagnostic test accuracy meta-analysis. Intensive Care Med. 2013;39:365-75
21. Human Microbiome Project Consortium. A framework for human microbiome research. Nature. 2012;486:215-21
22. Gevers D, Knight R, Petrosino JF, Huang K, McGuire AL, Birren BW, et al. The human microbiome project: a community resource for the healthy human microbiome. PLoS Biol. 2012;10:e1001377
23. Charlson ES, Diamond JM, Bittinger K, Fitzgerald AS, Yadav A, Haas AR, et al. Lung-enriched organisms and aberrant bacterial and fungal respiratory microbiota after lung transplant. Am J Respir Crit Care Med. 2012;186:536-45
24. Lozupone C, Cota-Gomez A, Palmer BE, Linderman DJ, Charlson ES, Sodergren E, et al. Widespread colonization of the lung by Tropheryma whipplei in HIV infection. Am J Respir Crit Care Med. 2013;187:1110-7
25. Dickson RP, Martinez FJ, Huffnagle GB. The role of the microbiome in exacerbations of chronic lung diseases. Lancet. 2014;384:691-702
26. Han MK, Huang YJ, Lipuma JJ, Boushey HA, Boucher RC, Cookson WO, et al. Significance of the microbiome in obstructive lung disease. Thorax. 2012;67:456-63
27. Bousbia S, Papazian L, Saux P, Forel JM, Auffray J-P, Martin C, et al. Repertoire of intensive care unit pneumonia microbiota. PLoS One. 2012;7:e32486
28. Toma I, Siegel MO, Keiser J, Yakovleva A, Kim A, Davenport L, et al. Singlemolecule long-read 16S sequencing to characterize the lung microbiome from mechanically ventilated patients with suspected pneumonia. J Clin Microbiol. 2014;52:3913-21
29. Dickson RP, Erb-Downward JR, Prescott HC, Martinez FJ, Curtis JL, Lama VN, et al. Analysis of culture-dependent versus culture-independent techniques for identification of bacteria in clinically obtained bronchoalveolar lavage fluid. J Clin Microbiol. 2014;52:3605-13
30. Charlson ES, Bittinger K, Haas AR, Fitzgerald AS, Frank I, Yadav A, et al. Topographical continuity of bacterial populations in the healthy human respiratory tract. Am J Respir Crit Care Med. 2011;184:957-63
31. Dickson RP, Erb-Downward JR, Freeman CM, McCloskey L, Beck JM, Huffnagle GB, et al. Spatial variation in the healthy human lung microbiome and the adapted island model of lung biogeography. Ann Am Thorac Soc. 2015;12:821-30
32. Anderson MJ. A new method for non-parametric multivariate analysis of variance. Austral Ecol. 2001;26:32-46
33. Kelly BJ, Gross R, Bittinger K, Sherrill-Mix S, Lewis JD, Collman RG, et al. Power and sample-size estimation for microbiome studies using pairwise distances and PERMANOVA. Bioinformatics. 2015;31:2461-8
34. Pan W. Akaike's information criterion in generalized estimating equations. Biometrics. 2001;57:120-5
35. Klompas M, Kleinman K, Khan Y, Evans RS, Lloyd JF, Stevenson K, et al. Rapid and reproducible surveillance for ventilator-associated pneumonia. Clin Infect Dis. 2012;54:370-7
36. Klompas M, Kulldorff M, Platt R. Risk of misleading ventilator-associated pneumonia rates with use of standard clinical and microbiological criteria. Clin Infect Dis. 2008;46:1443-6
37. Canadian Critical Care Trials Group. A randomized trial of diagnostic techniques for ventilator-associated pneumonia. N Engl J Med. 2006;355:2619-30
38. Panero A, Pacifico L, Rossi N, Roggini M, Chiesa C. Ureaplasma urealyticum as a cause of pneumonia in preterm infants: analysis of the white cell response. Arch Dis Child Fetal Neonatal Ed. 1995;73:F37-40
39. Viscardi RM, Hasday JD. Role of ureaplasma species in neonatal chronic lung disease: epidemiologic and experimental evidence. Pediatr Res. 2009; 65(5 Part 2):84R-90
40. Mourani PM, Harris JK, Sontag MK, Robertson CE, Abman SH. Molecular identification of bacteria in tracheal aspirate fluid from mechanically ventilated preterm infants. PLoS One. 2011;6:e25959
41. Raad I, Hachem R, Hanna H, Girgawy E, Rolston K, Whimbey E, et al. Treatment of vancomycin-resistant enterococcal infections in the immunocompromised host: quinupristin-dalfopristin in combination with minocycline. Antimicrob Agents Chemother. 2001;45:3202-4
42. American Thoracic Society, Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilatorassociated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005;171:388-416
43. Dethlefsen L, Relman DA. Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc Natl Acad Sci. 2011;108:4554-61
44. Raymond F, Ouameur AA, Déraspe M, Iqbal N, Gingras H, Dridi B, Leprohon P, Plante P-L, Giroux R, Bérubé E, Frenette J, Boudreau DK, Simard J-L, Chabot I, Domingo M-C, Trottier S, Boissinot M, Huletsky A, Roy PH, Ouellette M, Bergeron MG, Corbeil J: The initial state of the human gut microbiome determines its reshaping by antibiotics. ISME J. 2015. Online 11 September 2015
45. Scholte JBJ, van Dessel HA, Linssen CFM, Bergmans DCJJ, Savelkoul PHM, Roekaerts PMHJ, et al. Endotracheal aspirate and bronchoalveolar lavage fluid analysis: interchangeable diagnostic modalities in suspected ventilatorassociated pneumonia? J Clin Microbiol. 2014;52:3597-604
46. Bartlett JG, Mundy LM. Community-acquired pneumonia. N Engl J Med. 1995;333:1618-24
47. Johansson N, Kalin M, Tiveljung-Lindell A, Giske CG, Hedlund J. Etiology of community-acquired pneumonia: increased microbiological yield with new diagnostic methods. Clin Infect Dis. 2010;50:202-9
48. Jain S, Williams DJ, Arnold SR, Ampofo K, Bramley AM, Reed C, et al. Community-acquired pneumonia requiring hospitalization among U.S. children. N Engl J Med. 2015;372:835-45
49. Van der Eerden MM, Vlaspolder F, de Graaff CS, Groot T, Bronsveld W, Jansen HM, et al. Comparison between pathogen directed antibiotic treatment and empirical broad spectrum antibiotic treatment in patients with community acquired pneumonia: a prospective randomised study. Thorax. 2005;60:672-8
50. Bartlett JG. Decline in microbial studies for patients with pulmonary infections. Clin Infect Dis. 2004;39:170-2
51. Bartlett JG. Diagnostic tests for agents of community-acquired pneumonia. Clin Infect Dis. 2011;52 Suppl 4:S296-304
52. Caliendo AM, Gilbert DN, Ginocchio CC, Hanson KE, May L, Quinn TC, et al. Better tests, better care: improved diagnostics for infectious diseases. Clin Infect Dis. 2013;57 Suppl 3:S139-70
53. Charlson ES, Chen J, Custers-Allen R, Bittinger K, Li H, Sinha R, et al. Disordered microbial communities in the upper respiratory tract of cigarette smokers. PLoS One. 2010;5:e15216
54. Caporaso JG, Lauber CL, Walters WA, Berg-Lyons D, Lozupone CA, Turnbaugh PJ, et al. Global patterns of 16S rRNA diversity at a depth of millions of sequences per sample. Proc Natl Acad Sci U S A. 2011;108 Suppl 1:4516-22
55. Caporaso JG, Lauber CL, Walters WA, Berg-Lyons D, Huntley J, Fierer N, et al. Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms. ISME J. 2012;6:1621-4
56. Jackson DA. PROTEST: a PROcrustean Randomization TEST of community environment concordance. écoscience. 1995;2:297-303
57. Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello EK, et al. QIIME allows analysis of high-throughput community sequencing data. Nat Methods. 2010;7:335-6
58. McDonald D, Price MN, Goodrich J, Nawrocki EP, DeSantis TZ, Probst A, et al. An improved Greengenes taxonomy with explicit ranks for ecological and evolutionary analyses of bacteria and archaea. ISME J. 2012;6:610-8
59. Yilmaz P, Parfrey LW, Yarza P, Gerken J, Pruesse E, Quast C, et al. The SILVA and "All-species Living Tree Project (LTP)" taxonomic frameworks. Nucleic Acids Res. 2014;42(Database issue):D643-8
60. R Core Team. R: a language and environment for statistical computing. 2014
61. Dixon P. VEGAN, a package of R functions for community ecology. J Veg Sci. 2003;14:927-30
62. Yan J. Geepack: yet another package for generalized estimating equations. R News. 2002;2:12-4
63. Højsgaard S, Halekoh U, Yan J. The R package geepack for generalized estimating equations. J Stat Softw. 2005;15:1-11
64. Yan J, Fine J. Estimating equations for association structures. Stat Med. 2004; 23:859-74. discussion 875-7,879-80